ARCT peer analysis
Arcturus (ARCT) against its competitors: price, today's move, 1-year return and market value side by side.
ARCT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABUS Arbutus Biopharma | $4.14 | -1.66% | -14.46% | $834.03M |
| AVIR Atea Pharmaceuticals | $4.11 | -4.64% | 25.69% | – |
| BNTC Benitec Biopharma | $8.74 | -1.02% | -45.95% | $304.93M |
| INO Inovio | $2.02 | 235.33% | -14.41% | $62.29M |
| NVAX Novavax | $9.71 | -3.67% | 15.18% | $1.66B |
| PRQR ProQR Therapeutics | $1.39 | -3.47% | -48.90% | $196.16M |
| RCKT Rocket Pharmaceuticals | $2.44 | -3.94% | -34.05% | $267.85M |
| SLN Silence Therapeutics | $19.77 | 0.08% | 170.38% | – |
| VALN Valneva | $5.45 | -4.55% | -40.24% | – |
| VIR Vir Biotechnology | $11.19 | -0.97% | 88.70% | $1.91B |
| ARCT Arcturus | $11.03 | -9.22% | 14.54% | $313.51M |
- ARCT's peers: ABUS (Arbutus Biopharma), AVIR (Atea Pharmaceuticals), BNTC (Benitec Biopharma), INO (Inovio), NVAX (Novavax), PRQR (ProQR Therapeutics), RCKT (Rocket Pharmaceuticals), SLN (Silence Therapeutics).
Updated 2026-11-02 17:54 UTC